Business Standard

Moderna vaccine found 94.5% effective at preventing Covid-19

The highly positive readout comes just a week after a similar shot developed by Pfizer Inc and BioNTech SE was found to be more than 90% effective in an interim analysis

moderna
Premium

Cambridge, Massachusetts-based Moderna received $955 million from the U.S. Operation Warp Speed program to develop its vaccine

Robert Langreth | Bloomberg
Moderna Inc. said its Covid-19 vaccine was 94.5% effective in a preliminary analysis of a large late-stage clinical trial, another sign that a fast-paced hunt by scientists and pharmaceutical companies is paying off with potent new tools that could help control a worsening pandemic.
 
The highly positive readout comes just a week after a similar shot developed by Pfizer Inc. and BioNTech SE was found to be more than 90% effective in an interim analysis. Both shots rely on a technology called messenger RNA that has never been used to build an approved vaccine. Soon, millions of people around the

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Nov 16 2020 | 5:33 PM IST

Explore News

To read the full story, subscribe to BS Premium now, at just Rs 249/ month.

Key stories on business-standard.com are available only to BS Premium subscribers.

Register to read more on Business-Standard.com